Stock Track | Soleno Therapeutics Soars 6.26% Intraday on Strong Q4 Earnings

Stock Track02-26

Soleno Therapeutics' stock soared 6.26% during intraday trading on Wednesday, reflecting significant investor optimism.

The sharp rise appears to be driven by the company's strong fourth-quarter financial results. Soleno Therapeutics reported a basic earnings per share (EPS) of USD 0.82 and an operating income of USD 39.577 million for the quarter, indicating robust profitability and operational performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment